首页 › 基金 › EVENTIDE ASSET MANAGEMENT, LLC › COLL
EVENTIDE ASSET MANAGEMENT, LLC 对 COLL 的持仓历史
COLLEGIUM PHARMACEUTICAL INC · 医疗保健
EVENTIDE ASSET MANAGEMENT, LLC 在 Q2 2026 的 13F 申报中披露持有 COLL(COLLEGIUM PHARMACEUTICAL INC)1,361,228 股,市值约 US$49.3M,约占其申报组合的 0.66%,在其申报持仓中市值排名第 49 位。 EVENTIDE ASSET MANAGEMENT, LLC 最近 12 个申报季度中有 12 个季度披露了 COLL 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
EVENTIDE ASSET MANAGEMENT, LLC 对 COLL 的持仓演变
EVENTIDE ASSET MANAGEMENT, LLC 于 Q3 2023 首次披露 COLL 持仓:2,631,334 股(约 US$58.8M)。 该持仓在 Q1 2024 达到峰值 2,634,041 股,市值约 US$102.3M。 在 12 次申报中,EVENTIDE ASSET MANAGEMENT, LLC 0 次增持、4 次减持、7 次保持不变。 最近一期申报(Q2 2026)显示持股 1,361,228 股、市值约 US$49.3M,环比减持 -63,054 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 2.63M | $58.81M | 新进 |
| Q4 2023 | 2.63M | $80.97M | 持有 |
| Q1 2024 | 2.63M | $102.25M | 持有 |
| Q2 2024 | 2.63M | $84.84M | 持有 |
| Q3 2024 | 2.64M | $101.83M | 持有 |
| Q4 2024 | 2.64M | $75.60M | 持有 |
| Q1 2025 | 2.64M | $78.79M | 持有 |
| Q2 2025 | 2.64M | $78.11M | 持有 |
| Q3 2025 | 2.39M | $83.65M | 减持 |
| Q4 2025 | 1.88M | $86.88M | 减持 |
| Q1 2026 | 1.42M | $47.08M | 减持 |
| Q2 2026 | 1.36M | $49.27M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 COLL 与 13F 数据
COLL(COLLEGIUM PHARMACEUTICAL INC)属于医疗保健行业。我们追踪的基金中还有 32 只申报持有 COLL,申报仓位最大的包括:TENOR CAPITAL MANAGEMENT Co., L.P. (US$85.8M), GOLDENTREE ASSET MANAGEMENT LP (US$26.9M), SILVERBACK ASSET MANAGEMENT LLC (US$18.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 COLL 的基金
- TENOR CAPITAL MANAGEMENT Co., L.P. 68.81M 股 · $85.79M · Q2 2026
- GOLDENTREE ASSET MANAGEMENT LP 744.89K 股 · $26.92M · Q2 2026
- SILVERBACK ASSET MANAGEMENT LLC 15.30M 股 · $18.79M · Q2 2026
更多关于 EVENTIDE ASSET MANAGEMENT, LLC
常见问题
How long has EVENTIDE ASSET MANAGEMENT, LLC held COLL?
EVENTIDE ASSET MANAGEMENT, LLC has disclosed COLL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is EVENTIDE ASSET MANAGEMENT, LLC's current position in COLL?
As of Q2 2026, EVENTIDE ASSET MANAGEMENT, LLC holds 1.36M shares of COLL (COLLEGIUM PHARMACEUTICAL INC), valued at $49.27M, representing 0.66% of its reported portfolio and ranking #49.
Has EVENTIDE ASSET MANAGEMENT, LLC been buying or selling COLL?
In the latest 13F filing (Q2 2026), EVENTIDE ASSET MANAGEMENT, LLC reduced its position in COLL. The position peaked in Q1 2024 at 2.63M shares.
Which other funds hold COLL?
Other major institutional holders of COLL include TENOR CAPITAL MANAGEMENT Co., L.P., GOLDENTREE ASSET MANAGEMENT LP, SILVERBACK ASSET MANAGEMENT LLC, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.